MOESM9 of Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis

Additional file 9: Figure S8. Glucose measurements from ApoE-/- mice. ApoE-/- mice were fed a LFD or HFHCD for 2 weeks. From weeks 2-8 mice continued on the diets while also receiving daily subcutaneous injections of 300μg/kg liraglutide or PBS. Mice underwent glucose testing every 2 weeks via a tail-vein pin prick procedure. a| represents glucose levels during the liraglutide dosing period (week 2) and b| the glucose levels of mice for the whole study weeks 2-8. Error bars are representative of 16 mice per group (n=16). Statistical analysis was carried out performing a Kruskal–Wallis test followed by Dunn’s multiple comparison post-test. Statistical significance was considered when **p<0.01 while p>0.05 was considered NS. Stars above the boxes represent comparisons against the LFD group